Animals were randomly divided into TUDCA- or vehicle-treated groups. TUDCA (EMD Millipore, Billerica, MA) was dissolved in phosphate-buffered saline (Wisent Bio Products, Saint-Jean-Baptiste, QC, Canada) at 200 mg/ml and pH 7.5 as in previous studies using this dose (19, 48, 49). TUDCA (400 mg/kg) or an equal volume of sterile phosphate-buffered saline (vehicle) was administered daily via intraperitoneal injection beginning 3 days prior to surgery. Injections continued throughout the recovery and stimulation period and ended 1 day prior to tissue extraction to avoid the acute effects of drug treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.